Clinical Research Directory
Browse clinical research sites, groups, and studies.
Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
Sponsor: Peking Union Medical College Hospital
Summary
The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Official title: A Comparative Study of Al18F-NOTA-LM3 Versus 68Ga-DOTATATE PET/CT for Tumor Detection in Patients With Pheochromocytoma and Paraganglioma
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-08-06
Completion Date
2026-03-01
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
Diagnostic Test: Al18F-NOTA-LM3
Patients will receive a single intravenous injection of Al18F-NOTA-LM3. Subsequently, a PET/CT scan will be performed within 60 to 120 minutes post-injection.
Diagnostic Test: 68Ga-DOTATATE
Patients will receive a single intravenous injection of 68Ga-DOTATATE. Subsequently, a PET/CT scan will be performed within 40 to 60 minutes post-injection.
Locations (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China